While there are findings showing a significant decrease in filamin A levels in tissues from invasive breast cancer (BC) compared with benign disease on the one hand [45], tumorigenic enhancing activity in melanoma, lung and hepatocellular cancers has also been reported on the other [46,47,48]. This evidence concerns the gene FLNA and breast cancer.